Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Studies demonstrate differing response from left and right colon tumors


Significant genetic differences exist between tumors of the right and left side of the colon, according to data presented today at the 94th Annual Meeting of the American Association for Cancer Research (AACR), and these distinctions should be considered for future research and treatment.

"With emerging treatments directed toward specific molecular targets, there should be special emphasis on such an important differentiation," said Sanne Olesen, M.Sc. of biology, Aarhus University Hospital, Denmark, and lead investigator of the study conducted by scientists from Denmark and Finland. "Hopefully with this new understanding of the differences that exist in the colon, we can more efficiently treat cancer patients."

In the study, approximately 6,800 known genes were monitored for activity. Twenty single samples of normal colonic mucosa were compared to 25 single cancerous samples from both the left and right sides of the colon. Findings were validated by semi-quantitative, RealTime-PCR and immunohistochemistry, or observations of clinical reactions to the immune system.

Scientists found 58 genes that were dissimilar between the normal samples and the left-sided tumor samples, and 118 genes between the normal samples and the right-sided tumor samples. An additional 44 unique genes were found between the right- and left-sided tumor samples. Furthermore, scientists identified 30 genes which showed parallel expression in both sides, and therefore may be regarded as general tumor markers.

"This discovery may explain why some colorectal patients have responded to treatment while others did not," said Dr. Torben Orntoft, a professor at Aarhus University. "With new targeted therapies in development, our patients have a better chance of survival."

Colon cancer is one of the most common cancers found in men and women today. The American Cancer Society estimates that in 2003 there will be about 105,500 new cases of colon cancer in the United States, causing over 57,000 deaths

Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 20,000 laboratory and clinical scientists engaged in cancer research in the United States and more than 60 other countries. AACR’s mission is to accelerate the prevention and cure of cancer through research, education, communication and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). AACR’s annual meeting attracts more than 12,000 participants who share new and significant discoveries in the cancer field, and the AACR’s specialty meetings throughout the year focus on all the important areas of basic, translational and clinical cancer research.

Contact: Warren Froelich/AACR

Aimee Frank/Spectrum Science

In Washington, DC: (7/11-7/14)
Washington Convention Center

Warren Froelich | EurekAlert!

More articles from Health and Medicine:

nachricht Scientists develop tiny tooth-mounted sensors that can track what you eat
22.03.2018 | Tufts University

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Modular safety concept increases flexibility in plant conversion

22.03.2018 | Trade Fair News

New interactive map shows climate change everywhere in world

22.03.2018 | Earth Sciences

New technologies and computing power to help strengthen population data

22.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>